Tatva Chintan Pharma Chem Ltd
NSE:TATVA

Watchlist Manager
Tatva Chintan Pharma Chem Ltd Logo
Tatva Chintan Pharma Chem Ltd
NSE:TATVA
Watchlist
Price: 812.95 INR -3.58% Market Closed
Market Cap: 19B INR
Have any thoughts about
Tatva Chintan Pharma Chem Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one TATVA stock under the Base Case scenario is 1 402.23 INR. Compared to the current market price of 812.95 INR, Tatva Chintan Pharma Chem Ltd is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TATVA Relative Value
Base Case
1 402.23 INR
Undervaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.1
P/S
P/S
Price to Sales
5.1
vs History
95
vs Industry
9
Median 3Y
8.7
Median 5Y
8.7
Industry
1.5
Forward
4.6
More Details
108
P/E
P/E
Price to Earnings
108
vs History
4
vs Industry
7
Median 3Y
79.8
Median 5Y
79.7
Industry
21.7
Forward
123.8
More Details
48.2
P/OCF
P/OCF
Price to OCF
48.2
vs History
19
vs Industry
19
Median 3Y
24.7
Median 5Y
22.9
Industry
13
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-28.8
Median 5Y
-30.8
Industry
20.5
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
90
vs Industry
16
Median 3Y
7.4
Median 5Y
7.2
Industry
1.6
More Details
5.1
EV/S
EV/S
Enterprise Value to Sales
5.1
vs History
95
vs Industry
9
Median 3Y
8.6
Median 5Y
8.6
Industry
1.6
Forward
4.5
More Details
9.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.8
vs History
95
vs Industry
26
Median 3Y
17
Median 5Y
17.8
Industry
7.2
More Details
42.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
42.1
vs History
78
vs Industry
11
Median 3Y
53.6
Median 5Y
53.6
Industry
13.2
Forward
43.1
More Details
101.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
101.9
vs History
4
vs Industry
8
Median 3Y
62.1
Median 5Y
62.1
Industry
17.5
Forward
111.7
More Details
47.8
EV/OCF
EV/OCF
Enterprise Value to OCF
47.8
vs History
19
vs Industry
21
Median 3Y
23.7
Median 5Y
22.4
Industry
13.9
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-84.4
Median 5Y
-92.7
Industry
19.1
More Details
2.5
EV/IC
EV/IC
Enterprise Value to IC
2.5
vs History
90
vs Industry
12
Median 3Y
5.6
Median 5Y
5.4
Industry
1.3
More Details

Multiples Across Competitors

TATVA Competitors Multiples
Tatva Chintan Pharma Chem Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Tatva Chintan Pharma Chem Ltd
NSE:TATVA
19B INR 5.1 108 42.1 101.9
US
Sherwin-Williams Co
NYSE:SHW
86.9B USD 3.8 34 22 25.6
US
Ecolab Inc
NYSE:ECL
68B USD 4.3 33.3 21.2 28.9
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
10.1T JPY 4.1 19.7 8.7 11.5
CH
Givaudan SA
SIX:GIVN
36.5B CHF 5.1 35.4 24.7 31.6
US
Dupont De Nemours Inc
NYSE:DD
32.1B USD 2.6 40.2 12.6 21
CN
Wanhua Chemical Group Co Ltd
SSE:600309
232.7B CNY 1.2 15.3 16.7 16.7
US
PPG Industries Inc
NYSE:PPG
27.9B USD 1.5 18.8 11.4 14.1
CH
DSM-Firmenich AG
AEX:DSFIR
26.1B EUR 2.5 12.2 30.9 -60.5
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.2T INR 6.3 47.8 32.4 37.6
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK 9.3 54.8 28.9 37.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Tatva Chintan Pharma Chem Ltd
NSE:TATVA
Average EV/EBIT: 32.7
101.9
199%
0.5
US
Sherwin-Williams Co
NYSE:SHW
25.6
34%
0.7
US
Ecolab Inc
NYSE:ECL
28.9
52%
0.6
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
11.5
N/A N/A
CH
Givaudan SA
SIX:GIVN
31.6
44%
0.7
US
Dupont De Nemours Inc
NYSE:DD
21
83%
0.3
CN
Wanhua Chemical Group Co Ltd
SSE:600309
16.7
39%
0.4
US
PPG Industries Inc
NYSE:PPG
14.1
28%
0.5
CH
D
DSM-Firmenich AG
AEX:DSFIR
Negative Multiple: -60.5 N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
37.6
5%
7.1
DK
Novozymes A/S
CSE:NZYM B
37.9
N/A N/A

See Also

Summary
TATVA intrinsic value, competitors valuation, and company profile.
DCF Valuation
TATVA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TATVA stock valuation using valuation multiples.
Wall Street Estimates
TATVA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TATVA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.